--(BUSINESS WIRE)--Georgia Bio:
WHAT: Please join us at the 20th Annual Georgia Bio Innovation Summit. This 3-day virtual program is the largest life sciences industry conference to-date. It will feature eight sessions with leaders in industry, academia and government discussing major trends and issues in medical technology and devices; the changing landscape of the pharmaceutical industry; therapeutics, diagnostics and vaccines; global health; and new and exciting science at Georgia’s universities.
The sessions will include a conversation about the uniting power of scientific research and the strength and potential of Georgia’s health ecosystem with CDC Director, Dr. Rochelle P. Walensky and Emory University President, Gregory L. Fenves, and a conversation about navigating the funding landscape with senior leaders from J.P. Morgan and other capital strategies experts. Dr. Suresh Ramalingam, Executive Director of the Emory Winship Cancer Institute and U.S. Representative Drew Ferguson will give a video presentation on the advances in precision medicine, and the final day will feature a discussion led by EY Partner, Danica Dilligard, with Georgia C-Suite leaders about the value of innovation. View more here.
DATES: October 13-14 & 21, 2021
WHERE: Virtual Summit
WHY: Georgia Bio plays a unique role in organizing and coordinating the activities of many companies. Responding to the continuously evolving COVID-19 public health crisis, Georgia Bio will host a virtual summit to help companies working on treatments, diagnostics and vaccines discuss challenges and opportunities with government officials and other stakeholders. The event will touch on all aspects of the life sciences sector, from biopharma to medical devices, digital health, and public health.
For more information, please visit www.georgiabiosummit.org.
MEDIA REGISTRATION: Registration is complimentary for credentialed members of the news media. To request media registration, please contact Ryan Brooks at email@example.com | 404-805-2456.
ABOUT Georgia Bio (www.gabio.org) is the state’s private, non-profit life sciences association. Members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services. Georgia Bio is a division of the Center for Global Health Innovation.